Individuals who have suffered revision surgeries and pain and suffering from DePuy’s flawed ASR Hip Implant stand to receive a settlement – as DePuy parent company Johnson & Johnson has agreed to pay about $2.5 billion to compensate 8,598 patients.
The New York Times reports that, under the settlement agreement, Johnson & Johnson will cover an additional $3 billion to cover medical costs of the procedures.
This settlement seeks to address the claims of those ASR patients who have undergone a revision surgery as of August 31, 2013 and allows ASR patients who have yet to undergo a revision surgery to maintain their legal rights.
The deal was announced in open court on November 19, when the federal district court judge overseeing, MDL 2197, the DePuy ASR multi-district litigation, Hon. David A. Katz in Ohio held a hearing to consider the proposal.
In order to finally settle, at least 94% of the eligible claimants must agree to the deal. In order to particpate, a patient must be a U.S. citizen or resident who has had the ASR XL Acetabular Hip System or the ASR Hip Resurfacing system implanted in a U.S. Hospital or U.S. Military Hospital. The typical patient will receive about $250,000 before attorneys fees are calculated.
Sheller, P.C. represents numerous plaintiffs in the ASR litigation and settlement. If you have a DePuy ASR metal-on-metal implant and have questions about your rights under the settlement, please call us at (800) 883-2299.